Are we looking at the next big move in Maravai LifeSciences Holdings Inc (MRVI)?

Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) is -53.81% lower on its value in year-to-date trading and has touched a low of $4.52 and a high of $16.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MRVI stock was last observed hovering at around $6.68 in the last trading session, with the day’s loss setting it -0.07%.

Currently trading at $6.61, the stock is 17.52% and 10.26% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.14 million and changing -1.05% at the moment leaves the stock -38.37% off its SMA200. MRVI registered -53.19% loss for a year compared to 6-month loss of -48.40%. The firm has a 50-day simple moving average (SMA 50) of $2.17 and a 200-day simple moving average (SMA200) of $6.31.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a 27.85% gain in the last 1 month and extending the period to 3 months gives it a -28.92%, and is 6.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.94% over the week and 5.80% over the month.

Maravai LifeSciences Holdings Inc (MRVI) has around 610 employees, a market worth around $873.78M and $419.52M in sales. Current P/E ratio is 36.54 and Fwd P/E is 126.56. Profit margin for the company is 5.86%. Distance from 52-week low is 46.24% and -60.89% from its 52-week high. The company has generated returns on investments over the last 12 months (2.19%).

Maravai LifeSciences Holdings Inc (MRVI) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Maravai LifeSciences Holdings Inc (MRVI) is a “Overweight”. 11 analysts offering their recommendations for the stock have an average rating of 1.64, where 3 rate it as a Hold and 1 think it is a “Overweight”. 7 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Maravai LifeSciences Holdings Inc is expected to release its quarterly report on 02/21/2024.The EPS is expected to shrink by -99.82% this year.

Maravai LifeSciences Holdings Inc (MRVI) Top Institutional Holders

The shares outstanding are 131.69M, and float is at 109.05M with Short Float at 5.44%.

Maravai LifeSciences Holdings Inc (MRVI) Insider Activity

A total of 16 insider transactions have happened at Maravai LifeSciences Holdings Inc (MRVI) in the last six months, with sales accounting for 3 and purchases happening 13 times.

Maravai LifeSciences Holdings Inc (MRVI): Who are the competitors?

The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading -2.15% down over the past 12 months. Merck & Co. Inc. (MRK) that is -3.72% lower over the same period.